SMAD3 and melanoma: Mechanistic studies revealed that TGF-β/smad3 could induce the upregulation of caspase3 via stimulating S1PR1, while S1PR1 could control BCL-2 level by modifying BCL-2a expression in melanoma cells [32, 33].